Myomo Reports Third Quarter 2019 Results
CAMBRIDGE, Mass., November 12, 2019 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced its financial results for the third quarter ended September 30, 2019. Read more.
Myomo to Report Third Quarter 2019 Results on November 12, 2019
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it will release its financial results for the third quarter ended September 30, 2019 on Tuesday, November 12, 2019, after the market […]
Myomo Closes $3M Term Loan
Proceeds from Non-Dilutive Financing to be Used to Achieve Near-Term Milestones CAMBRIDGE, Mass., October 23, 2019 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the“Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it has entered into a term loan agreement […]
Myomo Announces Departure of Steve Sanghi from Board of Directors
Microchip Technology CEO will continue as advisor to Myomo and as an investor CAMBRIDGE, Mass., October 11, 2019 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced the resignation of Steve Sanghi from […]
Myomo Announces Technology Licensing Program for International Markets
CAMBRIDGE, Mass., August 21, 2019 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it has launched a business development program to bring its proprietary MyoPro orthotic product line to a greater […]
Myomo Reports Second Quarter 2019 Results
CAMBRIDGE, Mass., August 8, 2019 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced its financial results for the second quarter ended June 30, 2019. Read more.
Myomo to Report Second Quarter 2019 Results on August 8, 2019
Management to hold a conference call at 4:30 p.m. EDT CAMBRIDGE, Mass., August 1, 2019 – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it will release its financial results for the […]
United Brachial Plexus Network’s Annual Camp Features MyoPro® Adolescent Patients
Cambridge, MA. July 25 2019 – Myomo®, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, was recently a featured presenter at the United Brachial Plexus Network’s Camp UBPN, a worldwide initiative striving to inform and unite […]
Myomo®’s International Distribution Partners Launch Patient Screening Days
CAMBRIDGE, Mass.–(BUSINESS WIRE)– Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, announces that its international distributors in six countries are adopting the marketing model used successfully in the U.S. of introducing the MyoPro® powered orthosis […]
Myomo Announces First Insurance Reimbursements in European Markets
Cambridge, MA, June 17, 2019 — Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, announced today that its Orthotics and Prosthetics (O&P) distribution partners in Germany and Denmark have successfully obtained their first reimbursement decisions […]